Skip to main content

The Company held an analyst conference call on August 4, 2022 at 13.30 CET/07.30 EST. 

To launch the audio webcast recording of the call please click on this link

Presentation slides and a transcript of the call can be downloaded below.

"Pharming delivered strong half year results with total revenues up 4% compared to the same period last year. RUCONEST® sales growth was supported by increases in physicians prescribing and number of patients."

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline